Journal profile · Surgery
SURGICAL ONCOLOGY-OXFORD
ISSN 0960-7404 · eISSN 1879-3320 · Elsevier BV · ENGLAND · Quarterly · Founded 1992
SURGICAL ONCOLOGY-OXFORD: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.05; hybrid open access; APC about USD 3,890; median 78 days to acceptance (107 articles, last 24 months); community-reported acceptance: fairly easy; 127 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
SURGICAL ONCOLOGY-OXFORD is published by Elsevier BV and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Colorectal Cancer Surgical Treatments, Hepatocellular Carcinoma Treatment and Prognosis and Gastric Cancer Management and Outcomes, together about 23.3% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
A journal of cancer management & researchSurgical Oncology (SO) is an internationally peer reviewed journal publishing original research both clinical and translational, comprehensive reviews, multimedia articles, and meta-analyses that contribute to the advancement of knowledge in surgical oncology. Occasionally, SO publishes exceptional editorials and commentaries as they relate to selected papers. SO's articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation/outcomes.
From the journal's Aims & Scope
Research area (LetPub): Surgery
Editor-in-chief Aditi BhattPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 19, India 9, Italy 8, Japan 6, United Kingdom 5 (65 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Colorectal Cancer Surgical TreatmentsMedicine8.2%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine8%
- Gastric Cancer Management and OutcomesMedicine7.2%
- Pancreatic and Hepatic Oncology ResearchMedicine7%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.9%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine5.7%
- Sarcoma Diagnosis and TreatmentMedicine4.9%
- Intraperitoneal and Appendiceal MalignanciesMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Surgery | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Surgery | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.05LetPub ·
- Impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher)
- 4.7Publisher website ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 1.17LetPub ·
- h-index
- 58LetPub ·
- h-index
- 101OpenAlex ·
- i10-index
- 1,324OpenAlex ·
- 2-year mean citedness
- 1.49OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 24.03%LetPub ·
Volume
- Articles per year
- 105LetPub ·
Articles by year OpenAlex count · 2,927 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 186 | 51 | 27 |
| 2025 | 127 | 39 | 166 |
| 2024 | 111 | 40 | 440 |
| 2023 | 94 | 27 | 522 |
| 2022 | 151 | 37 | 1,766 |
| 2021 | 161 | 36 | 1,924 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
78 daysMedian, submission to acceptance · P25–P75 52 days – 114 days
- Acceptance to online
- median 2 days (107 articles)
- Submission to online
- median 82 days
- Sample
- 107 articles with submission and acceptance dates (340 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 51 daysPublisher website ·
- Submission to acceptance
- 99 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 3,640 / GBP 3,110 / JPY 482,480 | — | — | |
| Publisher website | USD 4,020 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10, with length limits
- commentaryCommentary Commentaries are commissioned by the Editor-in-Chief.Length not stated
- editorialEditorial Editorials are commissioned by the Editor-in-Chief.Length not stated
- literature reviewOriginal Research Article Reports of original studies presenting novel findings with clinical or scientific relevance in surgical oncology. Manuscripts should e…Length not stated
- meta-analysisOriginal Research Article Reports of original studies presenting novel findings with clinical or scientific relevance in surgical oncology. Manuscripts should e…main text ≤ 3,000 words · figures and tables ≤ 2 · references ≤ 10
- original research articleOriginal Research Article Reports of original studies presenting novel findings with clinical or scientific relevance in surgical oncology. Manuscripts should e…Length not stated
- protocolOriginal Research Article Reports of original studies presenting novel findings with clinical or scientific relevance in surgical oncology. Manuscripts should e…Length not stated
- reviewOriginal Research Article Reports of original studies presenting novel findings with clinical or scientific relevance in surgical oncology. Manuscripts should e…Length not stated
- review articleComprehensive, expert syntheses reviewing current knowledge and recent advances in important areas of surgical oncology. Authors should provide balanced discuss…main text ≤ 300 words · abstract ≤ 300 words · figures and tables ≤ 7 · references ≤ 150
- systematic reviewComprehensive and methodical literature review employing systematic search strategies and critical appraisal to synthesize evidence addressing a well-defined cl…main text ≤ 300 words · abstract ≤ 300 words · figures and tables ≤ 6 · references ≤ 150
- video articlesVideo Articles Video articles provide dynamic visual demonstrations pertinent to surgical oncology practice or research.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier BV
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1992
- ISSN
- 0960-7404
- Electronic ISSN
- 1879-3320
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about SURGICAL ONCOLOGY-OXFORD
What CAS zone is SURGICAL ONCOLOGY-OXFORD in?
In the 2025 upgraded edition of the CAS Journal Ranking, SURGICAL ONCOLOGY-OXFORD is in Zone 3 of Medicine, and in Zone 3 of the minor category Surgery / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of SURGICAL ONCOLOGY-OXFORD?
The latest impact factor listed by LetPub is 2.05; CiteScore 4.7, h-index 101.
How long does peer review take at SURGICAL ONCOLOGY-OXFORD?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 52–114 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of SURGICAL ONCOLOGY-OXFORD based?
Of the 65 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (19), India (9) and Italy (8). Counted from the institutions listed on the board page; for reference only.
Which databases index SURGICAL ONCOLOGY-OXFORD?
According to LetPub and DOAJ records, SURGICAL ONCOLOGY-OXFORD is indexed in SCIE and Scopus.
Is SURGICAL ONCOLOGY-OXFORD open access, and what is the APC?
SURGICAL ONCOLOGY-OXFORD is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .